REGN   $614.26  -1.81% Market Open

Regeneron Pharmaceuticals, Inc.
Total Cash 9.80B
totalCashPerShare 91.054
EBITDA 4.56B
Total Debt 2.70B
quickRatio 4.344
currentRatio 5.281
Total Revenue 13.85B
debtToEquity 9.221
Revenue/Share 128.691
ROA 0.073460005
ROE 0.17166
grossProfits
freeCashflow 2.22B
operatingCashflow 4.25B
earningsGrowth 0.30
revenueGrowth 0.106
grossMargins 0.50754
ebitdaMargins 0.32931998
operatingMargins 0.33211
profitMargins 0.33613998
enterpriseValue 82.15B
forwardPE 17.992756
floatShares 103.10M
sharesOutstanding 108.07M
sharesShort 1.72M
sharesShortPriorMonth 1.98M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.92%
Short Ratio help_outline 2.45%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 272.04
Price To Book help_outline 3.01
earningsQuarterlyGrowth 0.33
netIncomeToCommon 4.65B
trailingEps 40.39%
forwardEps 45.55%
enterpriseToEbitda 18.01
lastDividendValue
lastDividendDate
currentQuarterEstimate 10.97 4Q 2024
institutionsCount 1949
lastUpdated Nov. 6, 2024, 7:23 p.m.